| Company | Date | Position | Consensus β | Price Target β | 1-Yr Return | vs S&P 500 β |
|---|---|---|---|---|---|---|
|
MMSI
Merit Medical Systems
|
Oct 30, 2026 | BUY |
Strong Buy
+15.6% avg upside
16 analysts
|
$116.00
34.50% Upside
|
-2.1% | Β· |
|
BVS
Bioventus
|
Oct 28, 2026 | BUY |
Strong Buy
+5.1% avg upside
8 analysts
|
$18.00
35.02% Upside
|
-27.7% | Β· |
|
VMD
Viemed Healthcare
|
Oct 27, 2026 | BUY |
Strong Buy
+43.1% avg upside
4 analysts
|
$14.00
44.72% Upside
|
-6.3% | Β· |
|
HAE
Haemonetics
|
Oct 26, 2026 | BUY |
Strong Buy
-20.9% avg upside
18 analysts
|
$140.00
16.96% Upside
|
+1.8% | Β· |
|
XRAY
DENTSPLY SIRONA
|
Oct 26, 2026 | BUY |
Buy
+182.3% avg upside
25 analysts
|
$13.00
36.50% Upside
|
-2.9% | Β· |
|
USPH
US Physical Therapy
|
Oct 23, 2026 | BUY |
Strong Buy
+7.9% avg upside
12 analysts
|
$98.00
14.15% Upside
|
+13.0% | Β· |
|
ANIK
Anika Therapeutics
|
Oct 22, 2026 | BUY |
Strong Buy
+8.2% avg upside
5 analysts
|
$23.00
9.88% Upside
|
-39.1% | Β· |
|
HSIC
Henry Schein
|
Oct 21, 2026 | BUY |
Buy
+9.6% avg upside
25 analysts
|
$104.00
22.53% Upside
|
-0.1% | Β· |
|
OPK
Opko Health
|
Oct 16, 2026 | BUY |
Strong Buy
+284.6% avg upside
12 analysts
|
$2.25
35.53% Upside
|
+5.9% | Β· |
|
LMAT
Lemaitre Vascular
|
Oct 13, 2026 | BUY |
Strong Buy
+21.2% avg upside
16 analysts
|
$95.00
17.35% Upside
|
-6.7% | Β· |
|
OPCH
Option Care Health
|
Oct 07, 2026 | HOLD |
Buy
-10.6% avg upside
20 analysts
|
β | +2.0% | Β· |
|
LFCR
Lifecore Biomedical
|
Oct 01, 2026 | HOLD |
Buy
+49.2% avg upside
10 analysts
|
β | -2.1% | Β· |
|
OFIX
Orthofix Medical
|
Aug 06, 2026 | BUY |
Buy
+203.8% avg upside
15 analysts
|
$14.00
54.42% Upside
|
-37.1% | Β· |
|
OPNW
OpenWorld Inc
|
Jan 06, 2026 | BUY |
Strong Buy
+64.0% avg upside
2 analysts
|
$1.50
63.93% Upside
|
-93.9% | Β· |
|
MP
MP Materials
|
Jun 09, 2021 | BUY |
Strong Buy
+60.9% avg upside
23 analysts
|
β | +14.2% | Β· |
|
ROSGQ
Rosetta Genomics
|
Dec 18, 2017 | HOLD |
Buy
+4499900.1% avg upside
4 analysts
|
β | Β· | Β· |
|
LKQ
LKQ
|
Apr 25, 2016 | BUY |
Strong Buy
+88.4% avg upside
18 analysts
|
$30.00
61.71% Upside
|
-10.0% | Β· |
|
RHEP
Regional Health Properties
|
Aug 14, 2013 | BUY |
Strong Buy
+519.1% avg upside
1 analyst
|
$6.50
519.08% Upside
|
Β· | Β· |
Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.